Bruschettini competitive analysis

Latest publications and patents of Bruschettini New

Explore the latest publications and patents granted to Bruschettini, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Bruschettini

Sep 5, 2018Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative DisordersGranted And Under Opposition

Explore patent oppositions filed by Bruschettini against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Compositions For Improving Cell Viability And Methods Of Use ThereofAMYLYX PHARMACEUTICALSJan 11, 2021

Explore Bruschettini's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Sep 5, 2018Tauroursodeoxycholic Acid (Tudca) For Use In The Treatment Of Neurodegenerative Disorders1

Latest PTAB cases involving Bruschettini

Discover the latest PTAB cases involving Bruschettini, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Bruschettini with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
BRUSCHETTINI11 - - Aggressive
AMMELBURG5 - - - Highly Aggressive
AMYLYX PHARMACEUTICALS - 2 - - Non-Active